Sorrento Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Sorrento Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2023.
  • Sorrento Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2023 was $2.38M, a 15.3% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $2.38M -$428K -15.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.89M -$6.17M -68.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $3.69M -$1.15M -23.7% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $2.52M -$2.15M -46% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $2.8M +$755K +36.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $9.06M +$7.01M +342% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $4.83M +$2.78M +136% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $4.66M +$2.54M +119% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $2.05M -$1.82M -47% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $2.05M -$2.73M -57.1% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $2.05M -$2.73M -57.1% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $2.13M -$3.05M -58.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $3.87M -$1.37M -26.1% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $4.77M -$573K -10.7% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $4.78M -$795K -14.3% Dec 31, 2019 10-K 2021-02-19
Q3 2019 $5.18M +$2.44M +88.9% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $5.23M +$2.32M +79.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $5.35M +$2.27M +73.5% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $5.57M +$2.32M +71.4% Dec 31, 2018 10-K 2020-03-03
Q3 2018 $2.74M -$700K -20.3% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $2.91M -$635K -17.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $3.08M -$670K -17.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $3.25M -$659K -16.9% Dec 31, 2017 8-K 2019-06-17
Q3 2017 $3.44M +$1.93M +127% Sep 30, 2017 10-Q/A 2018-02-27
Q2 2017 $3.55M +$3.03M +577% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $3.75M +$3.2M +575% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $3.91M +$3.32M +563% Dec 31, 2016 10-K 2018-03-16
Q3 2016 $1.51M +$986K +187% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $524K -$78K -13% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $556K -$66K -10.6% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $590K +$258K +77.7% Dec 31, 2015 10-K/A 2017-03-27
Q3 2015 $527K +$203K +62.7% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $602K +$257K +74.5% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $622K +$374K +151% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $332K +$184K +124% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $324K -$129K -28.4% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $345K +$16.8K +5.12% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 $248K +$151K +155% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $148K +$99.4K +204% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $453K +$430K +1892% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $328K +$305K +1344% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 $97.1K +$74.4K +327% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $48.6K +$25.9K +114% Dec 31, 2012 10-K 2014-04-01
Q3 2012 $22.7K -$15.5K -40.6% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $22.7K -$15.5K -40.6% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $22.7K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $22.7K -$15.7K -40.8% Dec 31, 2011 10-K/A 2013-03-27
Q3 2011 $38.2K Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $38.2K Jun 30, 2011 10-Q 2011-08-12
Q4 2010 $38.4K Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.